glp-1 receptor antibody GLP1R (26196-1-AP) Structural insight into antibody-mediated antagonism

Table of Contents Diabetes and Atrial Fibrillation Risk Mechanisms Linking GLP-1 Therapy and AF Clinical Evidence and Observational Data Practical Implications and Research Gaps Diabetes and Atrial Fibrillation Risk Type 2 diabetes increases atrial fibrillation risk by roughly 30 to 40 percent

People with liver disease need caution because the liver is central to both ketone production and the metabolism of many GLP-1 medications

doi:10.23876/j.krcp.22.001 19

Find a clinic near you to get started What is a GLP-1 medication

These new treatment possibilities for clinicians, coupled with an increase in industry marketing and patients personal needs, have led to an explosion of prescriptions for these drugs especially in Western countries [9]